Theratechnologies Receives Complete Response Letter (CRL) from the FDA for the F8 Formulation of Tesamorelin sBLA

2 years ago

FDA requesting clarifications around chemistry, manufacturing and controls and additional information related to immunogenicityCRL does not impact commercial availability of…

CENTOGENE Receives French Research Tax Credit Accreditation

2 years ago

Partners able to claim up to 30% tax reliefCAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE)…

Valhalla’s Innovative Extra Strength Troches Set to Hit Dispensary Shelves Throughout Pennsylvania

2 years ago

TerrAscend expands its Valhalla product lineup to include one of the first 100mg edibles in The Keystone StateTORONTO, Jan. 24,…

RadNet’s Arizona Diagnostic Radiology Group Joint Venture Acquires Seven Outpatient Imaging Centers in Phoenix, Arizona

2 years ago

LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient…

EmpowerHER: A new professional network for female leaders in health launches

2 years ago

OTTAWA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The EmpowerHER Leadership Network proudly unveils its innovative networking platform, marking a transformative…

KFSH&RC Celebrates 25 Scientists Named in Stanford’s Top 2% Most-Cited Researchers Worldwide

2 years ago

KFSH&RC Celebrates 25 Scientists Named in Stanford's Top 2% Most-Cited Researchers Worldwide Highlight of the event honoring 25 scientists included…

Fighting leprosy with artificial intelligence: DAHW and Belle.ai join forces with Senegal’s Ministry of Health and Social Action to detect and combat neglected diseases

2 years ago

WÜRZBURG, Germany and CAMBRIDGE, Mass., Jan. 24, 2024 (GLOBE NEWSWIRE) -- DAHW German Leprosy and Tuberculosis Relief Association and BelleTorus…

Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases

2 years ago

Acquisition enriches Kyowa Kirin’s portfolio, enables the development of numerous promising candidates with a clinically differentiated platform, and helps to…

Coloplast Finance B.V. – Change of Auditor

2 years ago

Today, 24 January 2024, Coloplast Finance B.V. held its Annual General Meeting at which Ernst & Young Accountants LLP was…

Coloplast Finance B.V. – Decisions at the Annual General Meeting

2 years ago

On 24 January 2024, Coloplast Finance B.V. held its Annual General Meeting. At the Annual General Meeting, the sole shareholder,…